| Literature DB >> 28154178 |
Motofumi Kumazoe1, Yuki Nakamura1, Mai Yamashita1, Takashi Suzuki1, Kanako Takamatsu1, Yuhui Huang1, Jaehoon Bae1, Shuya Yamashita1, Motoki Murata1, Shuhei Yamada1, Yuki Shinoda2, Wataru Yamaguchi2, Yui Toyoda2, Hirofumi Tachibana3.
Abstract
Toll-like receptor 4 (TLR4) plays an essential role in innate immunity through inflammatory cytokine induction. Recent studies demonstrated that the abnormal activation of TLR4 has a pivotal role in obesity-induced inflammation, which is associated with several diseases, including hyperinsulinemia, hypertriglyceridemia, and cardiovascular disease. Here we demonstrate that (-)-epigallocatechin-3-O-gallate, a natural agonist of the 67-kDa laminin receptor (67LR), suppressed TLR4 expression through E3 ubiquitin-protein ring finger protein 216 (RNF216) up-regulation. Our data indicate cyclic GMP mediates 67LR agonist-dependent RNF216 up-regulation. Moreover, we show that the highly absorbent 67LR agonist (-)-epigallocatechin-3-O-(3-O-methyl)-gallate (EGCG3″Me) significantly attenuated TLR4 expression in the adipose tissue. EGCG3″Me completely inhibited the high-fat/high-sucrose (HF/HS)-induced up-regulation of tumor necrosis factor α in adipose tissue and serum monocyte chemoattractant protein-1 increase. Furthermore, this agonist intake prevented HF/HS-induced hyperinsulinemia and hypertriglyceridemia. Taken together, 67LR presents an attractive target for the relief of obesity-induced inflammation.Entities:
Keywords: 67-kDa laminin receptor; E3 ubiquitin ligase; EGCG; RNF216; Toll-like receptor 4 (TLR4); cyclic GMP (cGMP); hypertriglyceridemia; inflammation; obesity
Mesh:
Substances:
Year: 2017 PMID: 28154178 PMCID: PMC5354502 DOI: 10.1074/jbc.M116.755959
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157